{"disease":{"id":"diabetic-macular-edema","name":"diabetic macular edema"},"drugs":{"marketed":[{"drug_id":"ranibizumab-eqrn","indication_name":"Diabetic Macular Edema (DME)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"CIMERLI","generic_name":"RANIBIZUMAB-EQRN","company_name":"SANDOZ INC","drug_phase":"marketed","molecular_target":"","drug_class":"Vascular Endothelial Growth Factor Inhibitor [EPC]","quality_score":18,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05966753","title":"Describing Patient With DME, Their Patient Journey and Disease Progression","phase":"","overall_status":"COMPLETED","enrollment_count":221004,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT07308639","title":"DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.","phase":"","overall_status":"RECRUITING","enrollment_count":50000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04935749","title":"Epidemiologic Assessment of Diabetic Retinopathy in Egypt Using Ultrawide Field Fundus Photographs","phase":"","overall_status":"UNKNOWN","enrollment_count":10000,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT03665090","title":"Shanghai Cohort Study of Diabetic Eye Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":8000,"lead_sponsor_name":"Shanghai Eye Disease Prevention and Treatment Center","has_results":false},{"nct_id":"NCT05476926","title":"A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6000,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT03094819","title":"PROTECT2: Diabetes Care - Eye Exam","phase":"NA","overall_status":"UNKNOWN","enrollment_count":4500,"lead_sponsor_name":"Retinal Care Inc.","has_results":false},{"nct_id":"NCT06929143","title":"A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06213896","title":"Detecting Eye Diseases Via Hybrid Deep Learning Algorithms From Fundus Images","phase":"","overall_status":"COMPLETED","enrollment_count":1528,"lead_sponsor_name":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","has_results":false},{"nct_id":"NCT04432831","title":"A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1479,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06491914","title":"A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1118,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05368623","title":"Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device","phase":"","overall_status":"COMPLETED","enrollment_count":1100,"lead_sponsor_name":"RETINA-AI Health, Inc.","has_results":false},{"nct_id":"NCT06957080","title":"A Study of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1054,"lead_sponsor_name":"EyeBiotech Ltd.","has_results":false},{"nct_id":"NCT06439576","title":"Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06423274","title":"Comparing Artificial Intelligence for Assisted Diagnosis of Diabetic Retinopathy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT05222633","title":"Anti-VEGF in Real-world","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Wenbin Wei","has_results":false},{"nct_id":"NCT05182580","title":"Bangladesh PRODUCTIVity in Eyecare Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":993,"lead_sponsor_name":"Orbis","has_results":true},{"nct_id":"NCT03622593","title":"A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":951,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT03112005","title":"Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool","phase":"","overall_status":"COMPLETED","enrollment_count":942,"lead_sponsor_name":"Eyenuk, Inc.","has_results":false},{"nct_id":"NCT03622580","title":"A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":940,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT04805541","title":"Detection and Classification of Diabetic Retinopathy From Posterior Pole Images With A Deep Learning Model","phase":"","overall_status":"COMPLETED","enrollment_count":900,"lead_sponsor_name":"Ural Telekomunikasyon Sanayi Ticaret Anonim Sirketi","has_results":true},{"nct_id":"NCT05472376","title":"Real-Life Study in Diabetic Macular Edema","phase":"","overall_status":"COMPLETED","enrollment_count":854,"lead_sponsor_name":"Kocaeli University","has_results":false},{"nct_id":"NCT06680817","title":"A Real-World Study to Gain Clinical Insights Into Faricimab (FaReal Study)","phase":"","overall_status":"RECRUITING","enrollment_count":850,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT06723288","title":"A Study Conducted to Evaluate the Conjunctiva and Tenon's Capsule Status of Healthy Subjects and in Participants With Neovascular Age-related Macular Degeneration (nAMD)/Diabetic Macular Edema (DME)","phase":"","overall_status":"COMPLETED","enrollment_count":736,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04429503","title":"Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":660,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT04108156","title":"A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":634,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05080803","title":"Diabetic Macular Edema: Relevance of Staging Progression on Therapeutic Outcome","phase":"","overall_status":"COMPLETED","enrollment_count":608,"lead_sponsor_name":"European School of Advanced Studies in Ophthalmology","has_results":false},{"nct_id":"NCT04543331","title":"Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema","phase":"","overall_status":"COMPLETED","enrollment_count":572,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03481634","title":"Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":566,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05130385","title":"High Resolution Optical Coherence Tomography","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT06850922","title":"A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7446603 Administered Alone or in Combination With Aflibercept or Faricimab in Participants With Diabetic Macular Edema","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":546,"lead_sponsor_name":"Genentech, Inc.","has_results":false},{"nct_id":"NCT03917472","title":"Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":517,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05217680","title":"Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":510,"lead_sponsor_name":"Laboratorios Sophia S.A de C.V.","has_results":false},{"nct_id":"NCT04611152","title":"A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":460,"lead_sponsor_name":"Kodiak Sciences Inc","has_results":true},{"nct_id":"NCT04603937","title":"A Study to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":459,"lead_sponsor_name":"Kodiak Sciences Inc","has_results":true},{"nct_id":"NCT05675540","title":"Artificial Intelligence Diagnostic Aid","phase":"","overall_status":"UNKNOWN","enrollment_count":422,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT07515079","title":"Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":406,"lead_sponsor_name":"Bio-Thera Solutions","has_results":false},{"nct_id":"NCT03490318","title":"Effectiveness of Multimodal Imaging for the Evaluation of Retinal Oedema And New vesseLs in Diabetic Retinopathy","phase":"","overall_status":"COMPLETED","enrollment_count":401,"lead_sponsor_name":"Belfast Health and Social Care Trust","has_results":false},{"nct_id":"NCT04774822","title":"Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device","phase":"","overall_status":"COMPLETED","enrollment_count":397,"lead_sponsor_name":"RETINA-AI Health, Inc.","has_results":false},{"nct_id":"NCT05151731","title":"A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":394,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT07514559","title":"Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":393,"lead_sponsor_name":"Hospital Hietzing","has_results":false},{"nct_id":"NCT01875783","title":"OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits","phase":"NA","overall_status":"COMPLETED","enrollment_count":385,"lead_sponsor_name":"Joslin Diabetes Center","has_results":true},{"nct_id":"NCT02259088","title":"A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03481660","title":"A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03610646","title":"Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":355,"lead_sponsor_name":"Mylan Pharmaceuticals Inc","has_results":true},{"nct_id":"NCT01821677","title":"A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":354,"lead_sponsor_name":"Ampio Pharmaceuticals. Inc.","has_results":true},{"nct_id":"NCT04739306","title":"Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":348,"lead_sponsor_name":"Celltrion","has_results":true},{"nct_id":"NCT05324774","title":"Efficacy and Safety of 9MW0813 in Subjects With Diabetic Macular Edema","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":346,"lead_sponsor_name":"Mabwell (Shanghai) Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT06422507","title":"A Study to Learn More About How Well 8 Milligram Aflibercept Works and How Safe it is in Chinese Participants With Diabetic Macular Edema","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":333,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT06610747","title":"Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT","phase":"NA","overall_status":"RECRUITING","enrollment_count":308,"lead_sponsor_name":"Zhongshan Ophthalmic Center, Sun Yat-sen University","has_results":false},{"nct_id":"NCT02712008","title":"Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":302,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}